循環器ジャーナル71巻2号

2023年04月発行

特集 今だからこそ聞きたい心不全診療のこと。 Ⅱ．診断

急性心不全の治療選択につながる腎機能指標は何か？

著者： 那須崇人¹

所属機関： ¹岩手医科大学内科学講座循環器内科

ページ範囲：P.213 - P.218

POINT
・急性心不全は腎障害を合併する．
・WRFは予後不良な因子だが，全例当てはまるわけではない．
・予後不良なWRFは様々な指標があり，その意義を確認する必要がある．

参考文献

1）Kumar U, Wettersten N, Garimella PS. Cardiorenal Syndrome : Pathophysiology. Cardiol Clin 2019 ; 37 : 251-65.

2）Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock : This document was endorsed by the American College of Cardiology（ACC）, the American Heart Association（AHA）, the Society of Critical Care Medicine（SCCM）, and the Society of Thoracic Surgeons（STS）in April 2019. Catheter Cardiovasc Interv 2019 ; 94 : 29-37.

3）Damman K, Navis G, Voors AA, et al. Worsening renal function and prognosis in heart failure : systematic review and meta-analysis. J Card Fail 2007 ; 13 : 599-608.

4）Metra M, Davison B, Bettari L, et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail 2012 ; 5 : 54-62.

5）Inazumi H, Koyama S, Tanada Y, et al. Prognostic significance of changes in cystatin C during treatment of acute cardiac decompensation. J Cardiol 2016 ; 67 : 98-103.

6）Sokolski M, Zymliński R, Biegus J, et al. Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure. Eur J Heart Fail 2017 ; 19 : 760-7.

7）Clerico A, Galli C, Fortunato A, et al. Neutrophil gelatinase-associated lipocalin（NGAL）as biomarker of acute kidney injury : a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med 2012 ; 50 : 1505-17.

8）Doi K, Urata M, Katagiri D, et al. Plasma neutrophil gelatinase-associated lipocalin in acute kidney injury superimposed on chronic kidney disease after cardiac surgery : a multicenter prospective study. Crit Care 2013 ; 17 : R270.

9）Zhang H, Liu J, Li X, et al. MicroRNA-423-5p as a biomarker for early diagnosis and outcome prediction of acute kidney injury in patients with acute decompensated heart failure. Int J Urol 2021 ; 28 : 25-32.

10）Bruno N, ter Maaten JM, Ovchinnikova ES, et al. MicroRNAs relate to early worsening of renal function in patients with acute heart failure. Int J Cardiol 2016 ; 203 : 564-9.

11）Godwin JG, Ge X, Stephan K, et al. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci U S A 2010 ; 107 : 14339-44.

12）Schneider SIDR, Silvello D, Martinelli NC, et al. Plasma levels of microRNA-21, -126 and-423-5p alter during clinical improvement and are associated with the prognosis of acute heart failure. Mol Med Rep 2018 ; 17 : 4736-46.

13）Ramachandran K, Saikumar J, Bijol V, et al. Human miRNome profiling identifies microRNAs differentially present in the urine after kidney injury. Clin Chem 2013 ; 59 : 1742-52.

14）Shirakabe A, Hata N, Kobayashi N, et al. Worsening renal failure in patients with acute heart failure : the importance of cardiac biomarkers. ESC Heart Fail 2019 ; 6 : 416-27.

15）Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005 ; 352 : 15-35.